The U.S. FDA approved a pricey rare disease drug in September despite findings by its data reviewers that the treatment, ...

Biohaven is proposing troriluzole for the treatment of spinocerebellar ataxia, a group of rare, genetic diseases that lead to ...

Investing.com -- Biohaven (NYSE:BHVN) stock fell 44% after the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the company’s New Drug Application for VYGLXIA ...

Biohaven Ltd. (NYSE: BHVN) ("Biohaven"), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range ...

UCB has scored an FDA approval for ultra-rare disease treatment Kygevvi, continuing the positive momentum for the Belgian ...

Graves' disease is a disease in which thyroid function is excessively elevated due to an autoimmune response. Anti-thyroid ...

In Kentucky, a second wild deer has been confirmed with chronic wasting disease, a fatal neurologic disease that infects deer, elk and moose, but not people, ...

From weight gain and iodine to pregnancy and exercise, a thyroid expert busts 15 persistent myths about diagnosis, symptoms, ...

Autoimmune diseases are on the rise in the U.S., with as many as 50 million Americans affected. Learn what causes them—and which symptoms could help pinpoint your problem.

Officials with the Kentucky Department of Fish and Wildlife Resources announced Wednesday that Chronic Wasting Disease has been confirmed in a wild deer harvested by a hunter earlier this season ...

On October 29, HanAll Biopharma announced its provisional consolidated financial results for the third quarter of this year. The company reported ...

Clinical results showed that for six months after discontinuing Batoclimab, about 80% of patients maintained normal thyroid ...